Radiotherapy Research Trials in the UK: Secrets of Success

Clinical Oncology

Volumn 24, Issue 4, 2012, Pages 229-231

  Coles, C E ^a   Faivre Finn, C ^b  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; CANCER RESEARCH; CLINICAL PROTOCOL; COMMUNITY CARE; EDITORIAL; HUMAN; LUNG CANCER; PRIORITY JOURNAL; QUALITY CONTROL; TREATMENT PLANNING; UNITED KINGDOM;

CLINICAL TRIALS AS TOPIC; GREAT BRITAIN; HUMANS; NEOPLASMS; RESEARCH DESIGN;

EID: 84858796759     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.02.002     Document Type: Editorial

References (7)

1. Maughan T.S., Illidge T.M., Hoskin P., et al. Radiotherapy research priorities for the UK. Clin Oncol (R Coll Radiol) 2010, 22(8):707-709.
2. Donovan E.M., Ciurlionis L., Fairfoul J., et al. Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial). Int J Radiat Oncol Biol Phys 2011, 79(4):1064-1072.
3. Barton R., Mulvenna P., Faivre-Finn C., et al. Quality of life after treatment for brain metastases: interim data from the MRC QUARTZ clinic trial. J Thoracic Oncol 2011, 6(Suppl. 2):S1192.
4. Sydenham M.A., Bliss J., Venables K. Yarnold J on behalf of the START Trial Management Group. Evaluation of the effect of the START (Standardisation of Breast Radiotherapy) trial on radiotherapy practice in the UK. Clin Oncol (R Coll Radiol) 2004, 16(Suppl.):S31.
5. Faivre-Finn C., Blackhall F., Snee M., Harden S., Hulse P., Lorigan P. Improving survival with thoracic radiotherapy in patients with small cell lung cancer. The CONVERT and the REST Trials. Clin Oncol (R Coll Radiol) 2010, 22(7):547-549.
6. Groom N., Wilson E., Lyn E., Faivre-Finn C. Experiences of pre-trial quality assurance for the CONVERT trial. A multicentre randomised phase III trial for good performance status patients with limited stage small cell lung cancer. J Thoracic Oncol 2011, 6(Suppl. 2):S812.
7. Ferguson O., Fuller J., Faivre-Finn C., Bayman N. Optimising recruitment rates to radiotherapy clinical trials for patients with non-small cell lung cancer and brain metastases. Clin Oncol (R Coll Radiol) 2010, 22(7):616.